Published in Psychoneuroendocrinology on December 02, 2004
Prophylactic oophorectomy in premenopausal women and long-term health. Menopause Int (2008) 2.26
Estrogen and progestogen use in postmenopausal women: July 2008 position statement of The North American Menopause Society. Menopause (2008) 1.74
The developmental decrease in REM sleep: the role of transmitters and electrical coupling. Sleep (2008) 1.31
Estrogen therapy: is time of initiation critical for neuroprotection? Nat Rev Endocrinol (2009) 1.29
Hormone therapy and cognitive function. Hum Reprod Update (2009) 1.22
Critical window hypothesis of hormone therapy and cognition: a scientific update on clinical studies. Menopause (2013) 1.08
Hormonal influences on cognition and risk for Alzheimer's disease. Curr Neurol Neurosci Rep (2010) 0.94
Neuroprotective effects of estrogen therapy for cognitive and neurobiological profiles of monkey models of menopause. Am J Primatol (2009) 0.88
Lifetime hormonal factors may predict late-life depression in women. Int Psychogeriatr (2008) 0.83
Aging, estrogens, and episodic memory in women. Cogn Behav Neurol (2009) 0.83
The role of estrogen in the treatment of men with schizophrenia. Int J Endocrinol Metab (2013) 0.83
Effects of hormone therapy on cognition and mood. Fertil Steril (2014) 0.81
Estrogen modifies arousal but not memory for emotional events in older women. Neurobiol Aging (2007) 0.79
Hormone therapy does not modify emotion-induced brain activity in older women. Horm Behav (2009) 0.77
Postmenopausal syndrome. Indian J Psychiatry (2015) 0.76
Cognitive Effects of Systemic Therapy in Patients with Breast Cancer. Breast Care (Basel) (2009) 0.75
Treatment of hypertension in patients 80 years of age or older. N Engl J Med (2008) 21.04
Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial. BMJ (2007) 5.99
Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis. BMJ (2002) 5.36
Development and validation of a score to assess risk of adverse drug reactions among in-hospital patients 65 years or older: the GerontoNet ADR risk score. Arch Intern Med (2010) 3.05
Aortic stiffness is independently associated with rate of renal function decline in chronic kidney disease stages 3 and 4. Hypertension (2010) 2.93
Is augmentation index a good measure of vascular stiffness in the elderly? Age Ageing (2006) 2.44
Effect of galantamine hydrobromide in chronic fatigue syndrome: a randomized controlled trial. JAMA (2004) 2.36
Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease. Hepatology (2002) 2.26
Testosterone suppression in men with prostate cancer leads to an increase in arterial stiffness and hyperinsulinaemia. Clin Sci (Lond) (2003) 2.07
Does white coat hypertension require treatment over age 80?: Results of the hypertension in the very elderly trial ambulatory blood pressure side project. Hypertension (2012) 2.03
Estimation of central aortic pressure by SphygmoCor requires intra-arterial peripheral pressures. Clin Sci (Lond) (2003) 1.55
Safety, pharmacokinetics, and effects on cognitive function of multiple doses of GTS-21 in healthy, male volunteers. Neuropsychopharmacology (2002) 1.48
Living wills and the Mental Capacity Act: a postal questionnaire survey of UK geriatricians. Age Ageing (2006) 1.44
Cognitive and mood improvements of caffeine in habitual consumers and habitual non-consumers of caffeine. Psychopharmacology (Berl) (2005) 1.44
The human immunodeficiency virus and ageing. Age Ageing (2014) 1.42
Fetuin-A is an independent determinant of change of aortic stiffness over 1 year in non-diabetic patients with CKD stages 3 and 4. Nephrol Dial Transplant (2010) 1.39
Armodafinil for treatment of excessive sleepiness associated with shift work disorder: a randomized controlled study. Mayo Clin Proc (2009) 1.38
Orthostatic hypotension in Parkinson's disease: association with cognitive decline? Int J Geriatr Psychiatry (2006) 1.29
The efficacy and safety of armodafinil as treatment for adults with excessive sleepiness associated with narcolepsy. Curr Med Res Opin (2006) 1.28
The aging of elastic and muscular arteries: a comparison of diabetic and nondiabetic subjects. Diabetes Care (2003) 1.26
Ethnic differences in vascular stiffness and relations to hypertensive target organ damage. J Hypertens (2004) 1.18
Reboxetine versus paroxetine versus placebo: effects on cognitive functioning in depressed patients. Int Clin Psychopharmacol (2003) 1.14
A low glycaemic index breakfast cereal preferentially prevents children's cognitive performance from declining throughout the morning. Appetite (2007) 1.14
The effects of L-theanine, caffeine and their combination on cognition and mood. Biol Psychol (2007) 1.08
Strategies to reduce the risk of iatrogenic illness in complex older adults. Age Ageing (2013) 1.03
Phosphorylated fetuin-A-containing calciprotein particles are associated with aortic stiffness and a procalcific milieu in patients with pre-dialysis CKD. Nephrol Dial Transplant (2011) 1.02
The effect of modafinil on cognitive function in breast cancer survivors. Cancer (2009) 1.00
Muscarinic and nicotinic receptors synergistically modulate working memory and attention in humans. Int J Neuropsychopharmacol (2005) 0.98
Healthy middle-aged individuals are vulnerable to cognitive deficits as a result of increased arterial stiffness. J Hypertens (2010) 0.98
Selective effects of upper respiratory tract infection on cognition, mood and emotion processing: a prospective study. Brain Behav Immun (2007) 0.97
Elastin degradation is associated with progressive aortic stiffening and all-cause mortality in predialysis chronic kidney disease. Hypertension (2012) 0.97
Ethnic differences in skin microvascular function and their relation to cardiac target-organ damage. J Hypertens (2005) 0.97
Drug cessation in complex older adults: time for action. Age Ageing (2013) 0.95
Selective effects of acute serotonin and catecholamine depletion on memory in healthy women. J Psychopharmacol (2004) 0.93
Adverse drug reactions in elderly: challenges in identification and improving preventative strategies. Age Ageing (2009) 0.93
Pharmacodynamic effects of darifenacin, a muscarinic M selective receptor antagonist for the treatment of overactive bladder, in healthy volunteers. BJU Int (2005) 0.91
FGF-23 and osteoprotegerin are independently associated with myocardial damage in chronic kidney disease stages 3 and 4. Another link between chronic kidney disease-mineral bone disorder and the heart. Nephrol Dial Transplant (2011) 0.91
Instability of fibroblast growth factor-23 (FGF-23): implications for clinical studies. Clin Chim Acta (2011) 0.90
Serum calcification propensity predicts all-cause mortality in predialysis CKD. J Am Soc Nephrol (2013) 0.89
Vascular compliance is reduced in vascular dementia and not in Alzheimer's disease. Age Ageing (2008) 0.88
Albumin excretion rate and cardiovascular risk: could the association be explained by early microvascular dysfunction? Diabetes (2005) 0.88
Hallucinations predict attentional improvements with rivastigmine in dementia with lewy bodies. Dement Geriatr Cogn Disord (2004) 0.87
Poor agreement between commercial ELISAs for plasma fetuin-A: An effect of protein glycosylation? Clin Chim Acta (2010) 0.87
Adverse drug reactions in a population of hospitalized very elderly patients. Drugs Aging (2012) 0.87
The relationship between dipping profile in blood pressure and neurologic deficit in early acute ischemic stroke. J Stroke Cerebrovasc Dis (2010) 0.85
Effects of food on the single-dose pharmacokinetics/pharmacodynamics of tizanidine capsules and tablets in healthy volunteers. Clin Ther (2006) 0.84
An extract of Salvia (sage) with anticholinesterase properties improves memory and attention in healthy older volunteers. Psychopharmacology (Berl) (2008) 0.84
Repeatability of non-invasive measurement of intracerebral pulse wave velocity using transcranial Doppler. Clin Sci (Lond) (2005) 0.83
Prevalence of ambulatory hypotension in elderly patients with CKD stages 3 and 4. Nephrol Dial Transplant (2009) 0.83
Abdominal obesity and subclinical vascular damage in the elderly. J Hypertens (2010) 0.82
Advance end-of-life healthcare planning in an acute NHS hospital setting; development and evaluation of the Expression of Healthcare Preferences (EHP) document. Age Ageing (2008) 0.82
The effect of high lactose-isomaltulose on cognitive performance of young children. A double blind cross-over design study. Appetite (2011) 0.82
Recurrent strokes caused by a malpositioned pacemaker lead. Age Ageing (2011) 0.81
Differential effects of the aromas of Salvia species on memory and mood. Hum Psychopharmacol (2010) 0.81
Effect of androgen suppression compared with androgen receptor blockade on arterial stiffness in men with prostate cancer. J Androl (2009) 0.81
Estradiol treatment and its interaction with the cholinergic system: effects on cognitive function in healthy young women. Horm Behav (2008) 0.81
Anti-androgens increase N-terminal pro-BNP levels in men with prostate cancer. Clin Endocrinol (Oxf) (2007) 0.80
Evaluation of dementia rating scales in Parkinson's disease dementia. Am J Alzheimers Dis Other Demen (2009) 0.80
Enhanced external counterpulsation does not alter arterial stiffness in patients with angina. Clin Cardiol (2004) 0.80
Irbesartan improves arterial compliance more than lisinopril. Vasc Health Risk Manag (2009) 0.80
Is there an association between metabolic syndrome and cognitive function in very old adults? The Newcastle 85+ Study. J Am Geriatr Soc (2015) 0.80
Simultaneous depletion of serotonin and catecholamines impairs sustained attention in healthy female subjects without affecting learning and memory. J Psychopharmacol (2004) 0.79
The relationship between androgens and arterial stiffness in older men. J Am Geriatr Soc (2003) 0.79
Approaches to measuring the effects of wake-promoting drugs: a focus on cognitive function. Hum Psychopharmacol (2009) 0.79
Probiotics for the prevention and treatment of Clostridium difficile in older patients. Age Ageing (2012) 0.78
Acute ingestion of different macronutrients differentially enhances aspects of memory and attention in healthy young adults. Biol Psychol (2012) 0.78
Basal activity of the HPA axis and cognitive function in anorexia nervosa. Int J Neuropsychopharmacol (2002) 0.78
Combined D1/D2 receptor stimulation under conditions of dopamine depletion impairs spatial working memory performance in humans. Psychopharmacology (Berl) (2005) 0.78
Associations between cardiac target organ damage and microvascular dysfunction: the role of blood pressure. J Hypertens (2010) 0.76
The effects of acute tryptophan depletion on neuropsychological function, mood and movement in the healthy elderly. J Psychopharmacol (2011) 0.76
Peripheral arterial compliance differs between races: comparison among Asian, Afro-Caribbeans, and white Caucasians with type 2 diabetes. Diabetes Care (2005) 0.76
Experience from a pilot study of a nurse-led hypertension clinic in general practice. J Eval Clin Pract (2010) 0.76
Hyper- or hypotension in an older population: where do clinicians stand? Age Ageing (2009) 0.75
Factors associated with increasing vascular stiffness in PD. Nephrol Dial Transplant (2011) 0.75
The cognitive effects of modulating the glycine site of the NMDA receptor with high-dose glycine in healthy controls. Hum Psychopharmacol (2008) 0.75
Genetic variation of CHRNA4 does not modulate attention in Parkinson's disease. Neurosci Lett (2010) 0.75
The cognitive profile of type 1 Gaucher disease patients. J Inherit Metab Dis (2012) 0.75
Abdominal fat is dangerous for arteries even in older people. Age Ageing (2012) 0.75
FGF23 adds value to risk prediction in patients with chronic kidney disease. Bone (2012) 0.75
Non-pharmacological treatments for orthostatic hypotension. Age Ageing (2011) 0.75
Baseline plasma GABA: its relationship to the adverse effects of acute lorazepam administration on cognition in the elderly. Neurochem Res (2004) 0.75
Does a neuropsychological index of hemispheric lateralization predict onset of upper respiratory tract infectious symptoms? Br J Health Psychol (2009) 0.75
Left ventricular hypertrophy is a predictor of cardiovascular events in elderly hypertensive patients: Hypertension in the Very Elderly Trial. J Hypertens (2016) 0.75
Rationale and methodology of monitoring ambulatory blood pressure and arterial compliance in the Hypertension in the Very Elderly Trial. Blood Press Monit (2006) 0.75
Cognition assessment in paediatric clinical trials. Drug Discov Today (2007) 0.75
Prevalence and covariates of electrocardiographic left ventricular hypertrophy in the Hypertension in the Very Elderly Trial. J Hypertens (2013) 0.75